CoChat

Expanding the Clinical and Molecular Spectrum of PSMD12-Related Neurodevelopmental Syndrome: An Additional Patient and Review

Open access
Palumbo, Pietro, Palumbo, Orazio, Di Muro, Ester, Pia Leone, Maria, Castellana, Stefano, Biagini, Tommaso, Mazza, Tommaso, Leotta, Valentina, Carella, Massimo, Bukvic, Nenad · 2019 · Archives of Clinical and Medical Case Reports

The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.

Abstract

Degradation of proteins by the ubiquitin-proteasome system (UPS) is an essential biological process that eukaryotic cells use to regulate their functions and coordinate their signaling networks. In particular, it plays a crucial role in neuronal development regulating very important functional and morphological interplays of neurons, such as synaptic plasticity, neurotransmitter release and morphogenesis of axons. Pathogenic alterations of genes involved in the proteolysis by UPS have been associated with several neurodevelopmental disorders (NDDs) and human diseases, highlighting the importance of this regulatory mechanism to developmental processes and neurogenesis. Here, we describe a 19 years old male patient showing a syndromic form of NDD. The main clinical features are intellectual disability/speech delay, congenital anomalies and facial dysmorphisms. Through a targeted resequencing approach (TRS), we identified a missense variant in PSMD12, a gene recently associated to an emerging syndromic form of NDD, which encodes for the non-ATPase subunit of the 19S regulator of 26S proteasome complex. The variant described herein, inherited from the father with apparently borderline cognitive ability, is useful to expand the molecular spectrum of heterozygous PSMD12 mutations and to provide insight into the molecular pathogenesis of this new condition since it is, to the best of our knowledge, the first missense substitution to date reported in medical literature. More importantly, our study highlight once again the utility of next generation sequencing in establishing an etiological basis in clinically and genetically heterogeneous conditions such as NDDs, thus allowing a better diagnosis, counseling and management of affected patients and their families.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.26502/acmcr.96550088

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 6

  1. Rosenfeld JA, Patel A. Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies. J Pediatr Genet 6 (2017): 42-50.
  2. Khalil R, Kenny C, Hill RS, et al. PSMD12 haploinsufficiency in a neurodevelopmental disorder with autistic features. Am J Med Genet B Neuropsychiatr Genet 177 (2018): 736-745.
  3. Wang K, Li M, Hakonarson H. ANNOVAR: Functional annotation of genetic variants from next-generation sequencing data. Nucleic Acids Res 38 (2010): e164.
  4. McCarthy S, Das S, Kretzschmar W, et al. Haplotype Reference Consortium. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet 48 (2016): 1279-1283.
  5. Liu X, Wu C, Li C, et al. dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Non-synonymous and Splice Site SNVs. Human Mutation 37 (2016): 235-241.
  6. Viñas-Jornet M, Esteba-Castillo S, Gabau E, et al. A common cognitive, psychiatric, and dysmorphic phenotype in carriers of NRXN1 deletion. Mol Genet Genomic Med 2 (2014): 512-521.

Cited by

See all 5

Metadata

Authors
Palumbo, P., Palumbo, O., Di Muro, E., Pia Leone, M., Castellana, S., Biagini, T., Mazza, T., Leotta, V., Carella, M., & Bukvic, N.
Affiliations
  • Casa Sollievo della Sofferenza (IT)
  • Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
Venue
Archives of Clinical and Medical Case Reports
Published
2019
Volume
03
Issue
05
ISSN
2575-9655 (ISSN-L)
OpenAlex
W2960108397
Cited by
5
References
17
Citations by year
2024: 2 · 2023: 1 · 2022: 1 · 2019: 1
FWCI
0.30
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Archives of Clinical and Medical Case Reports (publishedVersion, cc-by)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
neurodevelopmental disorders, 19S proteasome, ubiquitin-proteasome system, missense mutations, intellectual disability, speech delay, congenital malformations, facial dysmorphism, molecular pathogenesis, genetic diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expanding the Clinical and Molecular Spectrum of PSMD12-Related Neurodevelopmental Syndrome: An Additional Patient and Review. https://app.cochat.ai/papers/10.26502/acmcr.96550088
The paper
Palumbo, P., Palumbo, O., Di Muro, E., Pia Leone, M., Castellana, S., Biagini, T., Mazza, T., Leotta, V., Carella, M., & Bukvic, N. (2019). Expanding the Clinical and Molecular Spectrum of PSMD12-Related Neurodevelopmental Syndrome: An Additional Patient and Review. Archives of Clinical and Medical Case Reports. https://doi.org/10.26502/acmcr.96550088

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.